Elevated Expression of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis

Possible Involvement of Proinflammatory Cytokines

Dina Saleh, Kanako Furukawa, Ming Sound Tsao, Azzam Maghazachi, Bryan Corrin, Masashi Yanagisawa, Peter J. Barnes, Adel Giaid

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymatically converted from a biologically inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE). Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immunohistochemistry and in situ hybridization. In normal lungs, focal moderate expression of all three molecules is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells. Serous bronchial glands also expressed ET-1 and ECE-1. In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells. ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity (P < 0.05). To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by radioimmunoassay and Northern blot. Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression. TNFα resulted in a significant increase in ECE-1 mRNA expression. These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF. In addition, increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.

Original languageEnglish (US)
Pages (from-to)187-193
Number of pages7
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume16
Issue number2
StatePublished - 1997

Fingerprint

Idiopathic Pulmonary Fibrosis
Endothelins
Endothelin-1
Cytokines
Enzymes
Lung
Epithelium
Tumor Necrosis Factor-alpha
Epithelial Cells
Bronchoconstrictor Agents
Alveolar Epithelial Cells
Messenger RNA
Vasoconstrictor Agents
Interleukin-1
Vascular Smooth Muscle
Northern Blotting
Smooth Muscle Myocytes
Endothelium
Radioimmunoassay
In Situ Hybridization

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

Cite this

Elevated Expression of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis : Possible Involvement of Proinflammatory Cytokines. / Saleh, Dina; Furukawa, Kanako; Tsao, Ming Sound; Maghazachi, Azzam; Corrin, Bryan; Yanagisawa, Masashi; Barnes, Peter J.; Giaid, Adel.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 16, No. 2, 1997, p. 187-193.

Research output: Contribution to journalArticle

Saleh, Dina ; Furukawa, Kanako ; Tsao, Ming Sound ; Maghazachi, Azzam ; Corrin, Bryan ; Yanagisawa, Masashi ; Barnes, Peter J. ; Giaid, Adel. / Elevated Expression of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis : Possible Involvement of Proinflammatory Cytokines. In: American Journal of Respiratory Cell and Molecular Biology. 1997 ; Vol. 16, No. 2. pp. 187-193.
@article{44e44eac3c264f8a9d89a29e9225bd7b,
title = "Elevated Expression of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis: Possible Involvement of Proinflammatory Cytokines",
abstract = "Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymatically converted from a biologically inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE). Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immunohistochemistry and in situ hybridization. In normal lungs, focal moderate expression of all three molecules is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells. Serous bronchial glands also expressed ET-1 and ECE-1. In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells. ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity (P < 0.05). To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by radioimmunoassay and Northern blot. Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression. TNFα resulted in a significant increase in ECE-1 mRNA expression. These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF. In addition, increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.",
author = "Dina Saleh and Kanako Furukawa and Tsao, {Ming Sound} and Azzam Maghazachi and Bryan Corrin and Masashi Yanagisawa and Barnes, {Peter J.} and Adel Giaid",
year = "1997",
language = "English (US)",
volume = "16",
pages = "187--193",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Elevated Expression of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis

T2 - Possible Involvement of Proinflammatory Cytokines

AU - Saleh, Dina

AU - Furukawa, Kanako

AU - Tsao, Ming Sound

AU - Maghazachi, Azzam

AU - Corrin, Bryan

AU - Yanagisawa, Masashi

AU - Barnes, Peter J.

AU - Giaid, Adel

PY - 1997

Y1 - 1997

N2 - Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymatically converted from a biologically inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE). Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immunohistochemistry and in situ hybridization. In normal lungs, focal moderate expression of all three molecules is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells. Serous bronchial glands also expressed ET-1 and ECE-1. In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells. ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity (P < 0.05). To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by radioimmunoassay and Northern blot. Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression. TNFα resulted in a significant increase in ECE-1 mRNA expression. These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF. In addition, increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.

AB - Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymatically converted from a biologically inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE). Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immunohistochemistry and in situ hybridization. In normal lungs, focal moderate expression of all three molecules is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells. Serous bronchial glands also expressed ET-1 and ECE-1. In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells. ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity (P < 0.05). To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by radioimmunoassay and Northern blot. Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression. TNFα resulted in a significant increase in ECE-1 mRNA expression. These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF. In addition, increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.

UR - http://www.scopus.com/inward/record.url?scp=0031065214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031065214&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 187

EP - 193

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -